Figure 3From: Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain Cost comparison assuming equal efficacy in (A) Germany and (B) Spain. Back to article page